Dermatology · Mc Lean, VA
NPI
1720422033
Since 2013
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
6711 Whittier Ave Ste 101
Mc Lean, VA, 22101
Phone (703) 495-2349
Groups this clinician bills Medicare through
Medicare paid, 2024
$277K
5,239 services
Medicare patients, 2024
536
Average age 76
Drug cost, 2024
$574K
922 prescriptions
Company payments, 2025
$536
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sanna Ronkainen was code 17003 (destruction skin lesion), 2,155 times for 298 patients. In total Sanna Ronkainen billed 5,239 services in 38 codes, and Medicare paid $277K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,155 | 298 | $6.34 | $14K |
| 99214 Office E&M - Established | Office | 556 | 308 | $108.72 | $60K |
| 17000 Destruction Skin Lesion | Office | 554 | 345 | $45.75 | $25K |
| 99213 Office E&M - Established | Office | 522 | 351 | $77.59 | $41K |
| 11102 Skin Biopsy | Office | 360 | 255 | $84.51 | $30K |
| 17110 Destruction Skin Lesion | Office | 269 | 161 | $105.75 | $28K |
| 11103 Skin Biopsy | Office | 167 | 98 | $49.24 | $8,223 |
| 17004 Destruction Skin Lesion | Office | 84 | 59 | $158.91 | $13K |
| 17111 Destruction Skin Lesion | Office | 71 | 38 | $124.17 | $8,816 |
| 12032 Wound Repair - All Levels | Office | 59 | 48 | $289.97 | $17K |
| 11602 Skin Lesion Excision | Office | 54 | 41 | $119.30 | $6,442 |
| 99212 Office E&M - Established | Office | 51 | 44 | $49.88 | $2,544 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 42 | 13 | $0.73 | $30.49 |
| 11900 Skin | Office | 41 | 21 | $43.08 | $1,766 |
| 10040 Removal or Shaving of Skin Growth | Office | 25 | 24 | $106.05 | $2,651 |
By year: 2022 $110K for 2,549 services; 2023 $256K for 5,361 services; 2024 $277K for 5,239 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sanna Ronkainen prescribed most often to Medicare patients was Ketoconazole, with 154 prescriptions and refills. In total Sanna Ronkainen wrote 922 Medicare prescriptions that cost $574K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 154 | 180 | 69 | $2,559 |
| Fluocinonide Generic | 69 | 69 | 56 | $3,429 |
| Clobetasol Propionate Generic | 64 | 71 | 29 | $3,651 |
| Fluorouracil Generic | 62 | 63 | 52 | $4,291 |
| Triamcinolone Acetonide Generic | 54 | 60 | 45 | $580 |
| Doxycycline Ir-Dr Doxycycline Monohydrate | 43 | 57 | Under 11 | $30K |
| Minoxidil Generic | 39 | 91 | Under 11 | $382 |
| Mupirocin Generic | 34 | 34 | 27 | $338 |
| Doxycycline Monohydrate Generic | 32 | 33 | 18 | $821 |
| Dupixent Syringe Dupilumab | 26 | 26 | Under 11 | $99K |
| Desonide Generic | 24 | 26 | 20 | $1,939 |
| Terbinafine Hcl Generic | 22 | 31 | Under 11 | $53.14 |
| Metronidazole Generic | 21 | 21 | 11 | $1,545 |
| Nystatin Generic | 21 | 21 | 12 | $315 |
| Prednisone Generic | 19 | 25 | Under 11 | $223 |
Brand drugs: 116 claims; generic drugs: 806 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sanna Ronkainen $536 ($536 in general payments such as food, travel and fees) from 11 companies. The largest payer was Lilly USA, LLC with $143.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 2 | $143 |
| Pfizer Inc. PFE | 1 | $125 |
| LEO Pharma Inc. | 2 | $56.78 |
| Abbvie Inc. ABBV | 2 | $48.15 |
| Janssen Biotech, Inc. JNJ | 2 | $41.9 |
| UCB, Inc. UCB.BR | 1 | $27.39 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $20.92 |
| Genzyme Corporation SNY | 1 | $20.79 |
| Incyte Corporation INCY | 1 | $17.79 |
| Galderma Laboratories, L.P. GALD.SW | 1 | $17.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.